202 related articles for article (PubMed ID: 17106669)
1. Cilostamide potentiates more the positive inotropic effects of (-)-adrenaline through beta(2)-adrenoceptors than the effects of (-)-noradrenaline through beta (1)-adrenoceptors in human atrial myocardium.
Christ T; Engel A; Ravens U; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):249-53. PubMed ID: 17106669
[TBL] [Abstract][Full Text] [Related]
2. Function of cardiac beta1- and beta2-adrenoceptors of newborn piglets: role of phosphodiesterases PDE3 and PDE4.
Galindo-Tovar A; Vargas ML; Kaumann AJ
Eur J Pharmacol; 2010 Jul; 638(1-3):99-107. PubMed ID: 20406625
[TBL] [Abstract][Full Text] [Related]
3. The effects of both noradrenaline and CGP12177, mediated through human beta1 -adrenoceptors, are reduced by PDE3 in human atrium but PDE4 in CHO cells.
Kaumann A; Semmler AB; Molenaar P
Naunyn Schmiedebergs Arch Pharmacol; 2007 Apr; 375(2):123-31. PubMed ID: 17318500
[TBL] [Abstract][Full Text] [Related]
4. Inotropy and L-type Ca2+ current, activated by beta1- and beta2-adrenoceptors, are differently controlled by phosphodiesterases 3 and 4 in rat heart.
Christ T; Galindo-Tovar A; Thoms M; Ravens U; Kaumann AJ
Br J Pharmacol; 2009 Jan; 156(1):62-83. PubMed ID: 19133992
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase PDE3 blunts the positive inotropic and cyclic AMP enhancing effects of CGP12177 but not of noradrenaline in rat ventricle.
Vargas ML; Hernandez J; Kaumann AJ
Br J Pharmacol; 2006 Jan; 147(2):158-63. PubMed ID: 16331293
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (-)-adrenaline mediated through mouse cardiac beta(1)-adrenoceptors.
Galindo-Tovar A; Kaumann AJ
Br J Pharmacol; 2008 Feb; 153(4):710-20. PubMed ID: 18084319
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol induces greater control of β2- than β 1-adrenoceptor-mediated inotropic and lusitropic effects by PDE3, while PDE4 has no effect in human failing myocardium.
Molenaar P; Christ T; Berk E; Engel A; Gillette KT; Galindo-Tovar A; Ravens U; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2014 Jul; 387(7):629-40. PubMed ID: 24668024
[TBL] [Abstract][Full Text] [Related]
8. PDE3, but not PDE4, reduces β₁ - and β₂-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients.
Molenaar P; Christ T; Hussain RI; Engel A; Berk E; Gillette KT; Chen L; Galindo-Tovar A; Krobert KA; Ravens U; Levy FO; Kaumann AJ
Br J Pharmacol; 2013 Jun; 169(3):528-38. PubMed ID: 23489141
[TBL] [Abstract][Full Text] [Related]
9. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta2 -adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling.
Molenaar P; Savarimuthu SM; Sarsero D; Chen L; Semmler AB; Carle A; Yang I; Bartel S; Vetter D; Beyerdörfer I; Krause EG; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):11-28. PubMed ID: 17295024
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterases do not limit beta1-adrenoceptor-mediated sinoatrial tachycardia: evidence with PDE3 and PDE4 in rabbits and PDE1-5 in rats.
Kaumann AJ; Galindo-Tovar A; Escudero E; Vargas ML
Naunyn Schmiedebergs Arch Pharmacol; 2009 Nov; 380(5):421-30. PubMed ID: 19693491
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterases PDE3 and PDE4 jointly control the inotropic effects but not chronotropic effects of (-)-CGP12177 despite PDE4-evoked sinoatrial bradycardia in rat atrium.
Galindo-Tovar A; Vargas ML; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2009 Apr; 379(4):379-84. PubMed ID: 19005642
[TBL] [Abstract][Full Text] [Related]
12. Effects of milrinone on contractility and cyclic adenosine monophosphate production induced by beta1- and beta2-adrenergic receptor activation in human myocardium.
Carceles MD; Fuentes T; Aroca V; Lopez J; Hernández J
Clin Ther; 2007 Aug; 29(8):1718-24. PubMed ID: 17919552
[TBL] [Abstract][Full Text] [Related]
13. Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart.
Molenaar P; Christ T; Ravens U; Kaumann A
Cardiovasc Res; 2006 Jan; 69(1):128-39. PubMed ID: 16225854
[TBL] [Abstract][Full Text] [Related]
14. Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 beta 1-adrenoceptors versus Gly389 beta 1-adrenoceptors in isolated human atrial myocardium.
Sandilands AJ; O'Shaughnessy KM; Brown MJ
Br J Pharmacol; 2003 Jan; 138(2):386-92. PubMed ID: 12540530
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of β2 -adrenoceptor-mediated inotropic and lusitropic response by PDE3 and PDE4 in failing and non-failing rat cardiac ventricle.
Afzal F; Aronsen JM; Moltzau LR; Sjaastad I; Levy FO; Skomedal T; Osnes JB; Qvigstad E
Br J Pharmacol; 2011 Jan; 162(1):54-71. PubMed ID: 21133887
[TBL] [Abstract][Full Text] [Related]
16. Ontogenic changes of the control by phosphodiesterase-3 and -4 of 5-HT responses in porcine heart and relevance to human atrial 5-HT(4) receptors.
Galindo-Tovar A; Vargas ML; Escudero E; Kaumann AJ
Br J Pharmacol; 2009 Jan; 156(2):237-49. PubMed ID: 19154438
[TBL] [Abstract][Full Text] [Related]
17. Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors.
Heubach JF; Blaschke M; Harding SE; Ravens U; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):380-90. PubMed ID: 12690430
[TBL] [Abstract][Full Text] [Related]
18. The phosphodiesterase 3 inhibitor cilostamide enhances inotropic responses to glucagon but not to dobutamine in rat ventricular myocardium.
Juan-Fita MJ; Vargas ML; Hernández J
Eur J Pharmacol; 2005 Apr; 512(2-3):207-13. PubMed ID: 15840406
[TBL] [Abstract][Full Text] [Related]
19. Single inhibition of either PDE3 or PDE4 unmasks β2-adrenoceptor-mediated inotropic and lusitropic effects in the left but not right ventricular myocardium of rat.
Soler F; Fernández-Belda F; Pérez-Schindler J; Hernández-Cascales J
Eur J Pharmacol; 2015 Oct; 765():429-36. PubMed ID: 26364538
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterases 2, 3 and 4 can decrease cardiac effects of H
Neumann J; Voss R; Laufs U; Werner C; Gergs U
Naunyn Schmiedebergs Arch Pharmacol; 2021 Jun; 394(6):1215-1229. PubMed ID: 33576869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
